South Delhi Pharma, New Delhi, India
BYNFEZIA PEN (octreotide acetate) injection, for subcutaneous use.
Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email firstname.lastname@example.org to discuss.
BYNFEZIA PEN is a prescription medicine. BYNFEZIA PEN used for cancerous tumors (carcinoid syndrome) or tumors called vasoactive intestinal peptide tumors (VIPomas).
INDICATIONS AND USAGE
BYNFEZIA Pen is a somatostatin analogue indicated for:
• Reduction of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) [somatomedin C] in adult patients with acromegaly who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses
• Treatment of severe diarrhea/flushing episodes associated with metastatic carcinoid tumors in adult patients
• Treatment of profuse watery diarrhea associated with vasoactive intestinal peptide tumors (VIPomas) in adult patients
DOSAGE FORMS & STRENGTHS
Injection: 2,500 mcg/mL octreotide as a 2.8 mL single-patient-use pen.
Manufactured By: Sun Pharmaceutical Industries, Inc.
Prescribing Information URL: Click Here
South Delhi Pharma can facilitate the supply of “BUPHENYL® (sodium phenylbutyrate) Tablets” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
Octreotide, sold under the brand name Sandostatin among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979, by the chemist Wilfried Bauer. It was approved for use in the United States in 1988.